Mitral Valve Disease Global Market Report 2024

Description

Mitral valve disease affects the mitral valve, which regulates blood flow between the heart's left atrium and left ventricle. This disorder can cause narrowing or leakage of the valve, disrupting normal blood circulation and leading to symptoms such as breathlessness, fatigue, and irregular heart rhythms. The primary goal in managing mitral valve disease is to maintain proper blood flow through the heart and prevent complications.

Key treatments for mitral valve disease include mitral valve repair, mitral valve replacement, cardiac resynchronization therapy, and mitral valve therapeutics. Mitral valve repair involves surgical or minimally invasive procedures to correct defects or leaks in the mitral valve, aiming to restore its normal function and prevent further health issues. This treatment is used to address conditions such as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation, and is administered in settings such as hospitals and ambulatory surgical centers.

The mitral valve disease market research report is one of a series of new reports from The Business Research Company that provides mitral valve disease market statistics, including the mitral valve disease industry global market size, regional shares, competitors with mitral valve disease market share, detailed mitral valve disease market segments, market trends, and opportunities, and any further data you may need to thrive in the mitral valve disease industry. These mitral valve disease market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mitral valve disease market size has grown strongly in recent years. It will grow from $2.75 billion in 2023 to $3 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth observed in the historic period can be credited to several factors including initiatives focused on patient education, favorable reimbursement policies and insurance coverage, increased healthcare spending, heightened awareness and screening campaigns, as well as expanded market penetration efforts.

The mitral valve disease market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period can be attributed to several key factors. These include the rising prevalence of mitral valve disease, growing adoption of minimally invasive techniques, continuous innovations in heart valve surgery, increased venture capital investments, and heightened interest among manufacturers. Major trends expected during this period encompass advancements in technology, particularly in transcatheter technologies, and continuous improvements in surgical procedures.

The mitral valve disease market is poised for growth due to the increasing prevalence of vascular heart diseases. Vascular heart diseases encompass various conditions affecting the heart's blood vessels, either supplying it or within the heart itself. Factors driving this rise include lifestyle choices, demographic shifts, medical conditions, environmental influences, and genetic factors. Conditions such as ischemic heart disease and hypertension, part of vascular heart diseases, can indirectly lead to mitral valve disease by compromising heart structure and function. For instance, recent data from the Australian Bureau of Statistics in December 2023 indicated that around 571,000 adults aged 18 and older in Australia were living with coronary heart disease (CHD), constituting 2.9% of the adult population. The prevalence of CHD increases notably with age, affecting approximately 11% of adults aged 75 and above. This trend underscores how vascular heart diseases contribute to the growing incidence of mitral valve disease.

Key players in the mitral valve disease market are focusing on developing stented tissue valves to meet the rising demand for minimally invasive treatment options. These valves are designed to offer durable performance and are considered alternatives to traditional surgical interventions. For example, Abbott Laboratories received FDA approval in September 2021 for Epic Plus and Epic Plus Supra stented tissue valves, designed for treating aortic or mitral valve disease. These devices utilize Abbott's Epic surgical valve platform and include anti-calcification technology. They feature a FlexFit polymer stent capable of withstanding pressures during balloon valvuloplasty, a pericardial shield to reduce abrasion risk, and a flexible cuff to minimize paravalvular leaks and accommodate patient anatomy.

In June 2021, Gyrus Capital acquired LivaNova PLC's heart valve business for $73 million. This acquisition encompassed LivaNova's heart valve products, such as the Perceval sutureless aortic valve and the Memo 4D mitral repair ring, along with their global operations. LivaNova PLC, a UK-based medical technology company specializing in cardiovascular diseases, including aortic valve disease, continues to be a key player in the industry.

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Europe was the largest region in the mitral valve disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mitral valve disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mitral valve disease market includes revenues earned by entities by providing services such as diagnostic imaging, surgical, and interventional procedures, alongside consultation, rehabilitation, and telemedicine services, catering to patient care and research needs. The market value includes the value of related goods sold by the service provider or included within the service offering. The mitral valve disease market also includes sales of valve repair devices, valve replacement devices, imaging and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mitral Valve Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mitral valve disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mitral valve disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mitral valve disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Mitral Valve Repair; Mitral Valve Replacement; Cardiac Resynchronization Therapy; Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis; Mitral Valve Prolapse; Mitral Valve Regurgitation
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Companies Mentioned: Pfizer Inc.; Bayer AG; Abbott Laboratories; Novartis AG; Medtronic plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18923

1. Executive Summary

2. Mitral Valve Disease Market Characteristics

3. Mitral Valve Disease Market Trends And Strategies

4. Mitral Valve Disease Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Mitral Valve Disease Market Size and Growth

5.1. Global Mitral Valve Disease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Mitral Valve Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Mitral Valve Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Mitral Valve Disease Market Segmentation

6.1. Global Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mitral Valve Repair
Mitral Valve Replacement
Cardiac Resynchronization Therapy
Mitral Valve Therapeutics
6.2. Global Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mitral Valve Stenosis
Mitral Valve Prolapse
Mitral Valve Regurgitation
6.3. Global Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Ambulatory Surgical Centers
Other End-Users

7. Mitral Valve Disease Market Regional And Country Analysis

7.1. Global Mitral Valve Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Mitral Valve Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Mitral Valve Disease Market

8.1. Asia-Pacific Mitral Valve Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Mitral Valve Disease Market

9.1. China Mitral Valve Disease Market Overview
9.2. China Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Mitral Valve Disease Market

10.1. India Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Mitral Valve Disease Market

11.1. Japan Mitral Valve Disease Market Overview
11.2. Japan Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Mitral Valve Disease Market

12.1. Australia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Mitral Valve Disease Market

13.1. Indonesia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Mitral Valve Disease Market

14.1. South Korea Mitral Valve Disease Market Overview
14.2. South Korea Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Mitral Valve Disease Market

15.1. Western Europe Mitral Valve Disease Market Overview
15.2. Western Europe Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Mitral Valve Disease Market

16.1. UK Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Mitral Valve Disease Market

17.1. Germany Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Mitral Valve Disease Market

18.1. France Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Mitral Valve Disease Market

19.1. Italy Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Mitral Valve Disease Market

20.1. Spain Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Mitral Valve Disease Market

21.1. Eastern Europe Mitral Valve Disease Market Overview
21.2. Eastern Europe Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Mitral Valve Disease Market

22.1. Russia Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Mitral Valve Disease Market

23.1. North America Mitral Valve Disease Market Overview
23.2. North America Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Mitral Valve Disease Market

24.1. USA Mitral Valve Disease Market Overview
24.2. USA Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Mitral Valve Disease Market

25.1. Canada Mitral Valve Disease Market Overview
25.2. Canada Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Mitral Valve Disease Market

26.1. South America Mitral Valve Disease Market Overview
26.2. South America Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Mitral Valve Disease Market

27.1. Brazil Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Mitral Valve Disease Market

28.1. Middle East Mitral Valve Disease Market Overview
28.2. Middle East Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Mitral Valve Disease Market

29.1. Africa Mitral Valve Disease Market Overview
29.2. Africa Mitral Valve Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Mitral Valve Disease Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Mitral Valve Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Mitral Valve Disease Market Competitive Landscape And Company Profiles

30.1. Mitral Valve Disease Market Competitive Landscape
30.2. Mitral Valve Disease Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bayer AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Medtronic plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Mitral Valve Disease Market Other Major And Innovative Companies

31.1. Boston Scientific Corporation
31.2. Edwards Lifesciences
31.3. ShockWave Medical Inc.
31.4. Artivion Inc.
31.5. TTK Health Care Limited
31.6. Braile Biomedica
31.7. JenaValve Technology Inc.
31.8. 4C Medical technologies
31.9. Labcor Laboratorios Ltda
31.10. CryoLife Inc.
31.11. Valcare Medical
31.12. Affluent Medical
31.13. Colibri Heart Valve LLC
31.14. Coramaze Technologies
31.15. Corcym UK Limited

32. Global Mitral Valve Disease Market Competitive Benchmarking

33. Global Mitral Valve Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Mitral Valve Disease Market

35. Mitral Valve Disease Market Future Outlook and Potential Analysis

35.1 Mitral Valve Disease Market In 2028 - Countries Offering Most New Opportunities
35.2 Mitral Valve Disease Market In 2028 - Segments Offering Most New Opportunities
35.3 Mitral Valve Disease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer